Chelsea Therapeutics (CHTP) Slashed 20%+ on Trade Resumption

December 4, 2012 4:40 PM EST Send to a Friend
Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) has resumed trading and is down 22 percent following an update on Northera.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

FDA, Trader Talk, Trading Halts

Add Your Comment